110 related articles for article (PubMed ID: 12182462)
1. Quantification of lymphocytes propagating from rat-kidney allografts--a tool to monitor anti-rejection treatment.
Engstrand M; Johnsson C; Larsson E; Tufveson G; Korsgren O
Transpl Immunol; 2002 Jun; 10(1):31-6. PubMed ID: 12182462
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo propagation and characterization of lymphocytes from rejecting rat-kidney allografts.
Engstrand M; Johnsson C; Korsgren O; Tufveson G
Transpl Immunol; 1999 Dec; 7(4):189-96. PubMed ID: 10638830
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte propagation from biopsies of kidney allografts.
Engstrand M; Larsson E; Naghibi M; Tufveson G; Korsgren O; Johnsson C
Transpl Immunol; 2006 Nov; 16(3-4):215-9. PubMed ID: 17138056
[TBL] [Abstract][Full Text] [Related]
4. The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection.
Zhang H; Horwitz L; Ruvolo P; Colombani P; Hess AD
Transplantation; 1995 Jul; 60(2):115-22. PubMed ID: 7624952
[TBL] [Abstract][Full Text] [Related]
5. Phenotyping of ex vivo propagated graft-infiltrating cells-a tool to monitor rejection in the early post-operative period.
Johnsson C; Lorant T; Quach M; Tufveson G
Transpl Immunol; 2006 Aug; 16(2):81-7. PubMed ID: 16860709
[TBL] [Abstract][Full Text] [Related]
6. Isolation of mouse-to-rat cardiac xenograft-infiltrating cells by ex vivo propagation.
Lorant T; Engstrand M; Tufveson G; Johnsson C
Xenotransplantation; 2002 May; 9(3):209-19. PubMed ID: 11983019
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood and intrahepatic subsets of T lymphocyte activation and function in liver allograft rejection and drug-induced tolerance in rats.
Davenport M; Peakman M; Dunne JB; Gonde CE; Vergani D; Williams R; Tredger JM
Transpl Immunol; 1996 Jun; 4(2):126-32. PubMed ID: 8843589
[TBL] [Abstract][Full Text] [Related]
9. Survival, function, morphology and serological aspects of rat renal allografts. Effect of short-term treatment with cyclosporine A, anti-CD4 and anti-interleukin-2 receptor monoclonal antibodies.
Steinbrüchel DA; Larsen S; Kristensen T; Starklint H; Koch C; Kemp E
APMIS; 1992 Aug; 100(8):682-94. PubMed ID: 1520480
[TBL] [Abstract][Full Text] [Related]
10. Function and surface phenotype of T lymphocytes infiltrating renal allografts in nonhuman primates treated with monoclonal antibodies.
Nocera A; Cosimi AB; Colvin RB; Gesner ML; Fuller TC
Transplantation; 1989 Nov; 48(5):732-41. PubMed ID: 2573179
[TBL] [Abstract][Full Text] [Related]
11. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
[TBL] [Abstract][Full Text] [Related]
12. Selective increase in CD4-positive graft-infiltrating mononuclear cells among the infiltrates in class I disparate kidney grafts undergoing rejection.
Giangrande I; Yamada K; Arn S; Lorf T; Sachs DH; LeGuern C
Transplantation; 1997 Mar; 63(5):722-8. PubMed ID: 9075845
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic renal allograft rejection in rats with a low-molecular-weight heparin (reviparin).
Braun C; Schultz M; Fang L; Schaub M; Back WE; Herr D; Laux V; Rohmeiss P; Schnuelle P; van der Woude FJ
Transplantation; 2001 Jul; 72(2):209-15. PubMed ID: 11477340
[TBL] [Abstract][Full Text] [Related]
14. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
Sakagawa T; Kiyochi H; Honda K; Kobayashi N
Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
[TBL] [Abstract][Full Text] [Related]
15. Late graft dysfunction after prolonged cold ischemia of the donor kidney: inhibition by cyclosporine.
Kouwenhoven EA; de Bruin RW; Heemann UW; Marquet RL; Ijzermans JN
Transplantation; 1999 Oct; 68(7):1004-10. PubMed ID: 10532542
[TBL] [Abstract][Full Text] [Related]
16. Lack of correlation between the induction of donor class I and class II major histocompatibility complex antigens and graft rejection.
Wood KJ; Hopley A; Dallman MJ; Morris PJ
Transplantation; 1988 Apr; 45(4):759-67. PubMed ID: 3282359
[TBL] [Abstract][Full Text] [Related]
17. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules.
Andersen CB; Ladefoged SD; Larsen S
APMIS; 1994 Jan; 102(1):23-37. PubMed ID: 7513171
[TBL] [Abstract][Full Text] [Related]
18. Importance of T cells to accelerated rejection and acceptance of renal allografts in sensitized rat recipients.
Heidecke CD; Zantl N; Maier S; Sewczik T; Westerholt S; Jakobs F; Westerholt A; Hancock WW; Kupiec-Weglinski JW
Transplantation; 1998 Nov; 66(10):1354-61. PubMed ID: 9846522
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome.
Bates WD; Davies DR; Welsh K; Gray DW; Fuggle SV; Morris PJ
Nephrol Dial Transplant; 1999 Oct; 14(10):2364-9. PubMed ID: 10528659
[TBL] [Abstract][Full Text] [Related]
20. Liver allograft rejection in rats depleted of CD8+ cells.
Ninova DI; Ferguson DM; Wettstein PJ; Krom RA
Transpl Int; 1996; 9(5):499-505. PubMed ID: 8875794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
